Joel Hellrup, PhD (he/him/his)

Head of Pharmaceutical R&D
Nanexa AB
Uppsala, Uppsala Lan, Sweden

Dr. Hellrup received his PhD in pharmaceutical sciences in 2016 from Uppsala University, Sweden. He joined Nanexa AB, Sweden as Formulation scientist in 2016. Today, Dr. Hellrup serves as Head of Pharmaceutical R&D at Nanexa. He is one of the key developers of the PharmaShell® technology, and is named as an inventor on several patent applications.

Disclosure information not submitted.

Presentation(s):

• Tech Forum: Innovative Strategies for Long-Acting Injectables: Exploring PharmaShell Technology

  Thursday, July 17, 2025
  9:00 AM – 10:00 AM EDT